Industry Research Reports

Home > Reports > Pharma & Healthcare > TB Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

TB Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 128 Pages

Report ld: 2331228

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.

The global market for TB Vaccines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for TB Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of TB Vaccines by region & country, by Type, and by Application.

The TB Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TB Vaccines.

Market Segmentation

Report Metric
Details
Report Title
TB Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global TB Vaccines Companies Covered
Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut
Global TB Vaccines Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TB Vaccines Market, Segment by Type
Immunotherapeutic Vaccines

Booster Vaccines

Others
Global TB Vaccines Market, Segment by Application
Hospitals

Private Clinics

Research Institutes
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of TB Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of TB Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 TB Vaccines Product Introduction
    1.2 Global TB Vaccines Market Size Forecast
        1.2.1 Global TB Vaccines Sales Value (2019-2030)
        1.2.2 Global TB Vaccines Sales Volume (2019-2030)
        1.2.3 Global TB Vaccines Sales Price (2019-2030)
    1.3 TB Vaccines Market Trends & Drivers
        1.3.1 TB Vaccines Industry Trends
        1.3.2 TB Vaccines Market Drivers & Opportunity
        1.3.3 TB Vaccines Market Challenges
        1.3.4 TB Vaccines Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global TB Vaccines Players Revenue Ranking (2023)
    2.2 Global TB Vaccines Revenue by Company (2019-2024)
    2.3 Global TB Vaccines Players Sales Volume Ranking (2023)
    2.4 Global TB Vaccines Sales Volume by Company Players (2019-2024)
    2.5 Global TB Vaccines Average Price by Company (2019-2024)
    2.6 Key Manufacturers TB Vaccines Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers TB Vaccines Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of TB Vaccines
    2.9 TB Vaccines Market Competitive Analysis
        2.9.1 TB Vaccines Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by TB Vaccines Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccines as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Immunotherapeutic Vaccines
        3.1.2 Booster Vaccines
        3.1.3 Others
    3.2 Global TB Vaccines Sales Value by Type
        3.2.1 Global TB Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global TB Vaccines Sales Value, by Type (2019-2030)
        3.2.3 Global TB Vaccines Sales Value, by Type (%) (2019-2030)
    3.3 Global TB Vaccines Sales Volume by Type
        3.3.1 Global TB Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global TB Vaccines Sales Volume, by Type (2019-2030)
        3.3.3 Global TB Vaccines Sales Volume, by Type (%) (2019-2030)
    3.4 Global TB Vaccines Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Private Clinics
        4.1.3 Research Institutes
    4.2 Global TB Vaccines Sales Value by Application
        4.2.1 Global TB Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global TB Vaccines Sales Value, by Application (2019-2030)
        4.2.3 Global TB Vaccines Sales Value, by Application (%) (2019-2030)
    4.3 Global TB Vaccines Sales Volume by Application
        4.3.1 Global TB Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global TB Vaccines Sales Volume, by Application (2019-2030)
        4.3.3 Global TB Vaccines Sales Volume, by Application (%) (2019-2030)
    4.4 Global TB Vaccines Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global TB Vaccines Sales Value by Region
        5.1.1 Global TB Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global TB Vaccines Sales Value by Region (2019-2024)
        5.1.3 Global TB Vaccines Sales Value by Region (2025-2030)
        5.1.4 Global TB Vaccines Sales Value by Region (%), (2019-2030)
    5.2 Global TB Vaccines Sales Volume by Region
        5.2.1 Global TB Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global TB Vaccines Sales Volume by Region (2019-2024)
        5.2.3 Global TB Vaccines Sales Volume by Region (2025-2030)
        5.2.4 Global TB Vaccines Sales Volume by Region (%), (2019-2030)
    5.3 Global TB Vaccines Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America TB Vaccines Sales Value, 2019-2030
        5.4.2 North America TB Vaccines Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe TB Vaccines Sales Value, 2019-2030
        5.5.2 Europe TB Vaccines Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific TB Vaccines Sales Value, 2019-2030
        5.6.2 Asia Pacific TB Vaccines Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America TB Vaccines Sales Value, 2019-2030
        5.7.2 South America TB Vaccines Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa TB Vaccines Sales Value, 2019-2030
        5.8.2 Middle East & Africa TB Vaccines Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions TB Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions TB Vaccines Sales Value
        6.2.1 Key Countries/Regions TB Vaccines Sales Value, 2019-2030
        6.2.2 Key Countries/Regions TB Vaccines Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States TB Vaccines Sales Value, 2019-2030
        6.3.2 United States TB Vaccines Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States TB Vaccines Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe TB Vaccines Sales Value, 2019-2030
        6.4.2 Europe TB Vaccines Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe TB Vaccines Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China TB Vaccines Sales Value, 2019-2030
        6.5.2 China TB Vaccines Sales Value by Type (%), 2023 VS 2030
        6.5.3 China TB Vaccines Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan TB Vaccines Sales Value, 2019-2030
        6.6.2 Japan TB Vaccines Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan TB Vaccines Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea TB Vaccines Sales Value, 2019-2030
        6.7.2 South Korea TB Vaccines Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea TB Vaccines Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia TB Vaccines Sales Value, 2019-2030
        6.8.2 Southeast Asia TB Vaccines Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia TB Vaccines Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India TB Vaccines Sales Value, 2019-2030
        6.9.2 India TB Vaccines Sales Value by Type (%), 2023 VS 2030
        6.9.3 India TB Vaccines Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Merck & Co.,Inc
        7.1.1 Merck & Co.,Inc Company Information
        7.1.2 Merck & Co.,Inc Introduction and Business Overview
        7.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Merck & Co.,Inc TB Vaccines Product Offerings
        7.1.5 Merck & Co.,Inc Recent Development
    7.2 Sanofi Pasteur
        7.2.1 Sanofi Pasteur Company Information
        7.2.2 Sanofi Pasteur Introduction and Business Overview
        7.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Sanofi Pasteur TB Vaccines Product Offerings
        7.2.5 Sanofi Pasteur Recent Development
    7.3 Japan BCG Laboratory
        7.3.1 Japan BCG Laboratory Company Information
        7.3.2 Japan BCG Laboratory Introduction and Business Overview
        7.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Japan BCG Laboratory TB Vaccines Product Offerings
        7.3.5 Japan BCG Laboratory Recent Development
    7.4 China National Biotec Group
        7.4.1 China National Biotec Group Company Information
        7.4.2 China National Biotec Group Introduction and Business Overview
        7.4.3 China National Biotec Group TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 China National Biotec Group TB Vaccines Product Offerings
        7.4.5 China National Biotec Group Recent Development
    7.5 Serum Institute
        7.5.1 Serum Institute Company Information
        7.5.2 Serum Institute Introduction and Business Overview
        7.5.3 Serum Institute TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Serum Institute TB Vaccines Product Offerings
        7.5.5 Serum Institute Recent Development
    7.6 India Pvt. Ltd
        7.6.1 India Pvt. Ltd Company Information
        7.6.2 India Pvt. Ltd Introduction and Business Overview
        7.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 India Pvt. Ltd TB Vaccines Product Offerings
        7.6.5 India Pvt. Ltd Recent Development
    7.7 InterVax Ltd
        7.7.1 InterVax Ltd Company Information
        7.7.2 InterVax Ltd Introduction and Business Overview
        7.7.3 InterVax Ltd TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 InterVax Ltd TB Vaccines Product Offerings
        7.7.5 InterVax Ltd Recent Development
    7.8 GreenSignal
        7.8.1 GreenSignal Company Information
        7.8.2 GreenSignal Introduction and Business Overview
        7.8.3 GreenSignal TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 GreenSignal TB Vaccines Product Offerings
        7.8.5 GreenSignal Recent Development
    7.9 Bio Pharma Limited
        7.9.1 Bio Pharma Limited Company Information
        7.9.2 Bio Pharma Limited Introduction and Business Overview
        7.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Bio Pharma Limited TB Vaccines Product Offerings
        7.9.5 Bio Pharma Limited Recent Development
    7.10 Statens Serum Institut
        7.10.1 Statens Serum Institut Company Information
        7.10.2 Statens Serum Institut Introduction and Business Overview
        7.10.3 Statens Serum Institut TB Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Statens Serum Institut TB Vaccines Product Offerings
        7.10.5 Statens Serum Institut Recent Development

 8 Industry Chain Analysis
    8.1 TB Vaccines Industrial Chain
    8.2 TB Vaccines Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 TB Vaccines Sales Model
        8.5.2 Sales Channel
        8.5.3 TB Vaccines Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. TB Vaccines Market Trends
    Table 2. TB Vaccines Market Drivers & Opportunity
    Table 3. TB Vaccines Market Challenges
    Table 4. TB Vaccines Market Restraints
    Table 5. Global TB Vaccines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global TB Vaccines Revenue Market Share by Company (2019-2024)
    Table 7. Global TB Vaccines Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global TB Vaccines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market TB Vaccines Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers TB Vaccines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers TB Vaccines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of TB Vaccines
    Table 13. Global TB Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global TB Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global TB Vaccines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global TB Vaccines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global TB Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global TB Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global TB Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global TB Vaccines Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global TB Vaccines Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global TB Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global TB Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global TB Vaccines Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global TB Vaccines Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global TB Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global TB Vaccines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global TB Vaccines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global TB Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global TB Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global TB Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global TB Vaccines Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global TB Vaccines Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global TB Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global TB Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global TB Vaccines Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global TB Vaccines Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global TB Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global TB Vaccines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global TB Vaccines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global TB Vaccines Sales Value by Region (2019-2024) & (%)
    Table 44. Global TB Vaccines Sales Value by Region (2025-2030) & (%)
    Table 45. Global TB Vaccines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global TB Vaccines Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global TB Vaccines Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global TB Vaccines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global TB Vaccines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global TB Vaccines Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global TB Vaccines Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions TB Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions TB Vaccines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions TB Vaccines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions TB Vaccines Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions TB Vaccines Sales Volume, (2025-2030) & (K Units)
    Table 57. Merck & Co.,Inc Company Information
    Table 58. Merck & Co.,Inc Introduction and Business Overview
    Table 59. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Merck & Co.,Inc TB Vaccines Product Offerings
    Table 61. Merck & Co.,Inc Recent Development
    Table 62. Sanofi Pasteur Company Information
    Table 63. Sanofi Pasteur Introduction and Business Overview
    Table 64. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Pasteur TB Vaccines Product Offerings
    Table 66. Sanofi Pasteur Recent Development
    Table 67. Japan BCG Laboratory Company Information
    Table 68. Japan BCG Laboratory Introduction and Business Overview
    Table 69. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Japan BCG Laboratory TB Vaccines Product Offerings
    Table 71. Japan BCG Laboratory Recent Development
    Table 72. China National Biotec Group Company Information
    Table 73. China National Biotec Group Introduction and Business Overview
    Table 74. China National Biotec Group TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. China National Biotec Group TB Vaccines Product Offerings
    Table 76. China National Biotec Group Recent Development
    Table 77. Serum Institute Company Information
    Table 78. Serum Institute Introduction and Business Overview
    Table 79. Serum Institute TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Serum Institute TB Vaccines Product Offerings
    Table 81. Serum Institute Recent Development
    Table 82. India Pvt. Ltd Company Information
    Table 83. India Pvt. Ltd Introduction and Business Overview
    Table 84. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. India Pvt. Ltd TB Vaccines Product Offerings
    Table 86. India Pvt. Ltd Recent Development
    Table 87. InterVax Ltd Company Information
    Table 88. InterVax Ltd Introduction and Business Overview
    Table 89. InterVax Ltd TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. InterVax Ltd TB Vaccines Product Offerings
    Table 91. InterVax Ltd Recent Development
    Table 92. GreenSignal Company Information
    Table 93. GreenSignal Introduction and Business Overview
    Table 94. GreenSignal TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. GreenSignal TB Vaccines Product Offerings
    Table 96. GreenSignal Recent Development
    Table 97. Bio Pharma Limited Company Information
    Table 98. Bio Pharma Limited Introduction and Business Overview
    Table 99. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Bio Pharma Limited TB Vaccines Product Offerings
    Table 101. Bio Pharma Limited Recent Development
    Table 102. Statens Serum Institut Company Information
    Table 103. Statens Serum Institut Introduction and Business Overview
    Table 104. Statens Serum Institut TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Statens Serum Institut TB Vaccines Product Offerings
    Table 106. Statens Serum Institut Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. TB Vaccines Downstream Customers
    Table 110. TB Vaccines Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. TB Vaccines Product Picture
    Figure 2. Global TB Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global TB Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global TB Vaccines Sales Volume (2019-2030) & (K Units)
    Figure 5. Global TB Vaccines Sales Price (2019-2030) & (USD/Unit)
    Figure 6. TB Vaccines Report Years Considered
    Figure 7. Global TB Vaccines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global TB Vaccines Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by TB Vaccines Revenue in 2023
    Figure 10. TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Immunotherapeutic Vaccines Picture
    Figure 12. Booster Vaccines Picture
    Figure 13. Others Picture
    Figure 14. Global TB Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global TB Vaccines Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global TB Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global TB Vaccines Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global TB Vaccines Price by Type (2019-2030) & (USD/Unit)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Private Clinics
    Figure 21. Product Picture of Research Institutes
    Figure 22. Global TB Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global TB Vaccines Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global TB Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global TB Vaccines Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global TB Vaccines Price by Application (2019-2030) & (USD/Unit)
    Figure 27. North America TB Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America TB Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe TB Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe TB Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific TB Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific TB Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America TB Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America TB Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa TB Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa TB Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions TB Vaccines Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions TB Vaccines Sales Volume (%), (2019-2030)
    Figure 39. United States TB Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States TB Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States TB Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe TB Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe TB Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe TB Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 45. China TB Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China TB Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 47. China TB Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan TB Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan TB Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan TB Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea TB Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea TB Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea TB Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia TB Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia TB Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia TB Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 57. India TB Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India TB Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 59. India TB Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 60. TB Vaccines Industrial Chain
    Figure 61. TB Vaccines Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.

The global market for TB Vaccines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation